Edwards' Sapien heart valve:
This article was originally published in Clinica
Executive Summary
Edwards Lifesciences has CE-marked for sale in Europe its Sapien transcatheter aortic heart valve technology with the RetroFlex transfemoral delivery system. The Irvine, California firm intends to begin selling the device in the fourth quarter of 2007. The Sapien bovine pericardial valve is implanted via a minimally-invasive procedure, and is designed to treat patients with severe aortic heart valve stenosis, who are considered to be high-risk or non-operable for conventional open-heart valve replacement surgery. With the RetroFlex transfemoral delivery system, the Sapien valve is compressed onto a balloon to the approximate diameter of a pencil, and is threaded through the patient's circulatory system from the leg and expanded securely into place directly over the diseased aortic valve.
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.